Logo
V

VENIPHARM GMBH

Venipharm is a French registered pharmaceutical company specialized on the European markets. We are particularly well positioned to either develop or co-develop, apply for and license out marketing authorizations linked to long-term supply of finished dosage forms. We are an independent, flexible and strongly customer-oriented company dedicated to generics and offering cooperation opportunities to external partners wishing to distribute their pharmaceutical products in the French and European markets. Venipharm puts to your service a dynamic team of chemists and pharmacists specialized in product development and regulatory affairs, who have acquired an outstanding reputation with customers and partners over the past ten years. More than 170 MAs from around 30 different molecules have already been granted to Venipharm and licensed out to generic companies.
Country/AreaFrance
IndustryManufacturing GeneralManufacturingPharmaceuticals
Company website
Company phone+33 1 47 11 04 47,+33 1 46 02 13 15
Established1999
Company Revenue$3,567,000
Number of employees<25
SIC Code28283
NAICS Code32325
http://www.linkedin.com/company/venipharm

Company News

Paracetamol Market to Witness Stunning Growth Worldwide : Venipharm, Novacyl, GlaxoSmithKline
Edison, NJ -- (SBWIRE) -- 05/04/2021 -- A new business intelligence report released by HTF MI with title "Global Paracetamol Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)" is designed covering micro level of analysis by manufacturers and key business segments. The Global Paracetamol Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundin
dateMay 4, 2021

Web Summary

Q1: What is the address of VENIPHARM GMBH's headquarters?
A1: The address of VENIPHARM GMBH's headquarters is 4, Bureaux de la Colline, 92210 Saint-Cloud, France.

Q2: What products does Hepartex offer?
A2: Hepartex offers APIs (Active Pharmaceutical Ingredients) and finished products for the pharmaceutical industry. They are experts in APIs and have developed a range of generic dossiers.

Q3: In which areas of activity is VENIPHARM GMBH involved?
A3: VENIPHARM GMBH is involved in three areas of activity: developing and licensing out their own generic dossiers, offering cooperation opportunities to manufacturing partners, and providing services in Regulatory and Lifecycle management.

Q4: What is the company's expertise in regulatory affairs?
A4: VENIPHARM GMBH has expertise in regulatory affairs, including registration phase with health authorities, registration dossier creation, coordination, and preparation. They also provide technical and regulatory assistance to generic companies.

Q5: How many marketing authorizations (MAs) does Hepartex have?
A5: Hepartex has more than 300 MAs from around 60 different molecules already been granted.

Q6: What is the company's approach to lifecycle management?
A6: VENIPHARM GMBH assists customers in transferring their products to cost-effective manufacturing partners to maintain long-term competitiveness, as they are well aware of the importance of lifecycle management in the generics industry.

Q7: How can one get more information about Hepartex or Venipharm?
A7: One can contact them through their website or by sending an email to hepartex@hepartex.com or venipharm@venipharm.com, or by calling +33 1 46 02 13 15 for Hepartex and +33 1 47 11 04 47 for Venipharm.

Q8: What is the company's VAT number?
A8: The VAT number of VENIPHARM GMBH is FR 52433736063.
Customs Data
As a purchaser
As a Supplier
Disable_icon
Get the Whole details
DisableData_png
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Disable_icon
Get the Whole details
DisableContact_png